Prostate cancer: should potency be preserved by deferring hormonal treatment in patients with asymptomatic metastatic disease?
Department of Urology, Pontefract General Infirmary, West Yorkshire, U.K.
M R
MR
Robinson
D007172:Erectile Dysfunction / Q000517:prevention & control*; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D011471:Prostatic Neoplasms / Q000628:therapy*; D011788:Quality of Life